Inspira Technologies Reports Positive Results from Clinical Study of HYLA Blood Sensor
Shots:
- The clinical study of AI-powered clip-on HYLA blood sensor (n=6) showed 96% accuracy vs. traditional blood test analyzers in open-heart surgery pts. The study was also used to test indicator for identifying oxygen deficiencies with 92.3% accuracy
- The study was conducted at Sheba Hospital, and Inspira plans to gather more patient data to enhance the system's AI for early detection diagnostics
- Inspira expects new results to support FDA submission in H2’25 and aims to deploy the INSPIRA ART technology in US hospitals for data collection, data validation and post-market validation
Ref: PR Newswire | Image: Inspira Technologies
Related News:- Daiichi Sankyo Reports Interim Data of P-III (DESTINY-Gastric04) Study Evaluating Enhertu in HER2+ Metastatic Gastric Cancer Patients
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
An avid reader and a dedicated learner, Prince works as a Content Writer at PharmaShots. Prince possesses an exceptional quality of breaking down the barriers of words by simplifying the terms in digestible chunks to make content readable and comprehensible. Prince likes to read books and loves to spend his free time learning and upskilling himself.
